Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

TxCell to Present on T Cellular Therapy for Autoimmune Diseases
Thursday, October 16, 2014
Dr. Miguel Forte will present at the 7th National Bio-Therapy Conference 2014, China.

Gyros Launches Gyrolab Protein A Kit for Efficient Quantification of Residual Protein A
Wednesday, October 08, 2014
Optimized kit for use with Gyros immunoassay platform.

Novosanis and University of Antwerp Receive Prestigious James Dyson Award
Tuesday, September 23, 2014
Company receives award as a national winner for its VAX-ID device.

Delenex Therapeutics AG Expands Pipeline
Tuesday, September 16, 2014
Extremely high potency and small size uniquely position products in dermatological and inflammatory diseases.

Abzena Appoints Experts for Relocation to New Headquarters
Wednesday, September 10, 2014
Laboratory relocation specialist Andrew Porter Limited has completed the move of PolyTherics, a wholly owned subsidiary of Abzena, to the Babraham Research Campus in Cambridge.

Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.

EpiCypher™ Announces Next-Generation Histone Peptide Array
Friday, September 05, 2014
EpiTitan™ to replace first-generation EpiGold™ array.

PerkinElmer Launches Innovative Multiplexing System
Thursday, September 04, 2014
AlphaPlex™ reagent technology provides life sciences researchers with more data in less time.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 358
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv